CASMI

Dr Sarah Garner

Dr Sarah Garner PhD, BPharm is a pharmacist specialising in Health Technology Assessment (HTA). Sarah is the Associate Director for R&D at the UK’s National Institute for Health and Clinical Excellence (NICE) and is responsible for the planning and delivery of NICE’s R&D agenda relating to methodology and clinical research.

Sarah is also Project Director for Adaptive Licensing at the newly formed Centre for the Advancement of Sustainable Medical Innovation, a partnership between the University of Oxford and UCL. In 2010-11 Sarah was a Harkness Fellow in Healthcare Policy and Practice in the United States. Her research examined the impact of comparative effectiveness research and HTA on innovation. Sarah is working with the NEWDIGS team at MIT to identify R&D policy solutions using a systems approach.

Sarah is on the UK Regulation of Medicines Review Panel, which carries out independent reviews of UK licensing authority decisions.